Sectors

The OATV-backed user interface software provider increased its valuation fivefold to $10bn in a round co-led by Morgan Stanley and Durable Capital Partners.

Citi, Cuna Mutual Group and New York Life have contributed to a series D round for the financial advice provider at a valuation topping $1bn.

GV, Latacora and Salesforce Ventures helped the app development technology provider close its latest round, which will support hiring and research and development.

The AstraZeneca, Sinopharm and Eli Lilly-backed oncology drug developer has revealed its intention to go public in a Hong Kong IPO that could reportedly fetch $250m.

The data warehousing software developer has received cash from investors including GV, Telstra Ventures, M12 and National Grid Ventures to bring its total funding to $195m.

Gene therapy developer Corlieve, which utilises University of Bordeaux, Aix Marseille University, CNRS and Inserm research, is set to be acquired by peer QniQure for about $55m.

Allied Minds had invested over $50m in New York University RAM technology spinout Spin Memory, which has decided to liquidate its assets to pay creditors.

GV notched up an exit as cancer therapy developer Monte Rosa Therapeutics priced an upsized initial public offering at the top of its range.

DNA Capital has returned to lead a $59.5m round for the Qualcomm Ventures-backed digital prescription startup.

Applied Materials and Arm were among the investors in RAM technology developer Spin Memory, which has elected to liquidate its assets to pay creditors.

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.